Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Twist Bioscience Corp Director's Dealing 2020

May 22, 2020

31873_dirs_2020-05-22_b499fa2c-f6dc-43bf-8896-29e97de42c4f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2020-05-20

Reporting Person: Leproust Emily M. (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-05-20 Common Stock S 29045 $39.5385 Disposed 817017 Direct
2020-05-20 Common Stock S 11311 $40.2063 Disposed 805706 Direct
2020-05-20 Common Stock S 600 $41.07 Disposed 805106 Direct
2020-05-20 Common Stock F 3007 $39.76 Disposed 802099 Direct
2020-05-21 Common Stock S 500 $37.7775 Disposed 801599 Direct
2020-05-21 Common Stock S 5700 $39.1706 Disposed 795899 Direct
2020-05-21 Common Stock S 8238 $39.8994 Disposed 787661 Direct

Footnotes

F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F2: Represents the weighted average sales price per share. The shares sold at prices ranging from $38.90 to $39.89 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F3: Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).

F4: Represents the weighted average sales price per share. The shares sold at prices ranging from $39.90 to $40.85 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F5: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e).

F6: Represents the weighted average sales price per share. The shares sold at prices ranging from $37.51 to $38.11 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F7: Represents the weighted average sales price per share. The shares sold at prices ranging from $38.52 to $39.50 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F8: Represents the weighted average sales price per share. The shares sold at prices ranging from $39.52 to $40.18 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.